National Council for Prescription Drug Programs indexing - billing unit

Manufacturer: National Council for Prescription Drug Programs
Effective date: 2013-06-04
Label type: Indexing - Billing Unit
Version: 1
Source: full-release
Hydrated at: 2026-06-05 04:09:16

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
60505-3220-6	EA - Each	60505-3220	24b6ed0d-e34d-47ff-9136-daec471ffea3	1	2013-06-04

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
60505-3220	60505-3220-6

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A091072-001	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	2013-05-16
A091072-002	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	2013-05-16
A091072-003	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	2013-05-16
A091072-004	RIVASTIGMINE TARTRATE	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	2013-05-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 172 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A091072-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	2013-05-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A091072-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	2013-05-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A091072-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	2013-05-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A091072-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	2013-05-16	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A091072-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	2013-05-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A091072-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	2013-05-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A091072-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	2013-05-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A091072-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	2013-05-16	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A091072-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	2013-05-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091072-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	2013-05-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091072-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	2013-05-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091072-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	2013-05-16	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091072-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	2013-05-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091072-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	2013-05-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091072-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	2013-05-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091072-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	2013-05-16	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A091072-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	2013-05-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091072-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	2013-05-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091072-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	2013-05-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091072-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	2013-05-16	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091072-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	2013-05-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091072-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	2013-05-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091072-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	2013-05-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091072-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	2013-05-16	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091072-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	2013-05-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091072-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	2013-05-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091072-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	2013-05-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091072-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	2013-05-16	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091072-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	2013-05-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091072-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	2013-05-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091072-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	2013-05-16	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091072-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	2013-05-16	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091072-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	2013-05-16	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091072-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	2013-05-16	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091072-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	2013-05-16	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091072-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	2013-05-16	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091072-001	RIVASTIGMINE TARTRATE	EQ 1.5MG BASE	CAPSULE / ORAL	2013-05-16	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091072-002	RIVASTIGMINE TARTRATE	EQ 3MG BASE	CAPSULE / ORAL	2013-05-16	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091072-003	RIVASTIGMINE TARTRATE	EQ 4.5MG BASE	CAPSULE / ORAL	2013-05-16	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091072-004	RIVASTIGMINE TARTRATE	EQ 6MG BASE	CAPSULE / ORAL	2013-05-16	`5bbf6a4d5a75…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A091072-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A091072-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A091072-003	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A091072-004	AB	1	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	A091072-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A091072-002	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A091072-003	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A091072-004	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A091072-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A091072-002	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A091072-003	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A091072-004	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A091072-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A091072-002	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A091072-003	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A091072-004	AB	1	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.